GPs must not prescribe semaglutide for CVD risk without ‘written confirmation’ of funding

GPs should get written confirmation of ICB commissioning before prescribing semaglutide for CVD risk reduction.

GP Press Digest · Story from Pulse

GPs must not prescribe semaglutide for CVD risk without ‘written confirmation’ of funding

Published 7 September 2026 · Contracts & funding, Prescribing & medicines

← GP Press Digest – week to 12 September 2026 · Story 1 of 2

PulseNews

In brief GPs should get written confirmation of ICB commissioning before prescribing semaglutide for CVD risk reduction.

Read the full article at Pulse ↗

Headline and link from Pulse (pulsetoday.co.uk); summary by BLMC. Pulse articles may need free registration. Inclusion isn't endorsement.

Next story →RCGP opposes NHS England's proposals for neighbourhood contracts 'in their current form'
In this digest · GP Press Digest – week to 12 September 2026
  1. GPs must not prescribe semaglutide for CVD risk without 'written confirmation' of funding
  2. RCGP opposes NHS England's proposals for neighbourhood contracts 'in their current form'